Filing Details
- Accession Number:
- 0001209191-20-008895
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-02-12 17:24:32
- Reporting Period:
- 2020-02-10
- Accepted Time:
- 2020-02-12 17:24:32
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1446372 | M Paul Silva | C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210 | Svp & Controller | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2020-02-10 | 4,673 | $240.95 | 25,550 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2020-02-11 | 380 | $243.59 | 25,170 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-02-11 | 1,560 | $244.90 | 23,610 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-02-11 | 1,700 | $245.89 | 21,910 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-02-11 | 1,120 | $246.84 | 20,790 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-02-11 | 1,102 | $247.93 | 19,688 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | F | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 169 | Indirect | 401(k) |
Footnotes
- Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1.
- Open market sales reported on this line occurred at a weighted average price of $243.59 (range $243.29 to $244.28).
- Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- Open market sales reported on this line occurred at a weighted average price of $244.90 (range $244.37 to $245.33).
- Open market sales reported on this line occurred at a weighted average price of $245.89 (range $245.39 to $246.30).
- Open market sales reported on this line occurred at a weighted average price of $246.84 (range $246.46 to $247.38).
- Open market sales reported on this line occurred at a weighted average price of $247.93 (range $247.58 to $248.55).
Billionaire Hedge Funds
